Fidelity International’s Intellia Therapeutics NTLA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-83,926
| Closed | -$597K | – | 1005 |
|
2025
Q1 | $597K | Sell |
83,926
-75,745
| -47% | -$539K | ﹤0.01% | 766 |
|
2024
Q4 | $1.86M | Buy |
159,671
+140,608
| +738% | +$1.64M | ﹤0.01% | 686 |
|
2024
Q3 | $392K | Buy |
19,063
+598
| +3% | +$12.3K | ﹤0.01% | 796 |
|
2024
Q2 | $413K | Buy |
18,465
+8,841
| +92% | +$198K | ﹤0.01% | 767 |
|
2024
Q1 | $265K | Buy |
9,624
+681
| +8% | +$18.7K | ﹤0.01% | 789 |
|
2023
Q4 | $273K | Buy |
+8,943
| New | +$273K | ﹤0.01% | 758 |
|
2023
Q2 | – | Sell |
-80,000
| Closed | -$2.98M | – | 837 |
|
2023
Q1 | $2.98M | Sell |
80,000
-115
| -0.1% | -$4.29K | ﹤0.01% | 633 |
|
2022
Q4 | $2.8M | Buy |
+80,115
| New | +$2.8M | ﹤0.01% | 642 |
|